Biotech · Private company · Norwell, MA, US
Remedi, Inc.
Track this companyFree. Adds Remedi, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- Enhancing Oral Bioavailability of DMT with a Proprietary Reversible Monoamine Oxidase Inhibitor (RIMA) for Alcohol Use Disorder TherapyFiscal year 2026 · $293.7KNIH RePORTER 1R43AA032947-01 · fetched Nov 12, 2026